Tianjin Ringpu Bio Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Ringpu Bio Technology Co Ltd with three other
companies in this sector in China:
Walvax Biotechnology Company Limited
sales of 1.01 billion Chinese Renmimbi [US$145.69 million]
of which 58%
was Vaccine Product Subcontract),
Chongqing Zhifei Biological Products Co Ltd
(711.35 million Chinese Renmimbi [US$103.08 million]
of which 99%
was Biological Product), and
Zhongyuan Union Cell & Gene Engineering Corp Ltd
(706.86 million Chinese Renmimbi [US$102.43 million]
of which 60%
was Scientific research service).
During the year ended December of 2015, sales at
Tianjin Ringpu Bio Technology Co Ltd were 792.32 million Chinese Renmimbi (US$114.82 million).
increase of 35.4%
versus 2014, when the company's sales were 585.12 million Chinese Renmimbi.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
364.8% in 2015, from
3.44 million Chinese Renmimbi to 15.97 million Chinese Renmimbi.
Tianjin Ringpu Bio Technology Co Ltd also saw significant increases in sales in
Veterinary Biological Products (up 46.4% to 475.22 million Chinese Renmimbi)